Rural counties in the U.S. are experiencing increasing rates of hepatocellular carcinoma incidence and mortality while urban ...

The study adds to growing evidence that immunotherapy and chemoembolization prolong progression-free survival.

Using the Chart Your Fart app, Australians self-reported an average of five flatus per day, with a higher number recorded among males versus females, at 5.2 versus 4.8. (JAMA Network Open) ...

Combining standard transarterial chemoembolization (TACE) with the immunotherapy-based STRIDE regimen improved ...

Oral drug shows responses across 6 tumor types in patients resistant to immunotherapy, with durable benefits and manageable safety in a ...

Obesity has been associated with multiple gastrointestinal cancers, but patients with these malignancies and obesity who have ...

Across multiple solid tumors, GLP-1 RA initiation after cancer diagnosis is associated with reduced metastatic progression.

For more than two decades, transarterial chemoembolization (TACE) has served as the global standard of care for patients with ...

(Alliance News) - AstraZeneca PLC on Monday posted positive phase-three trial results for a combination of its drugs Imfinzi and Imjudo to treat a form of liver cancer. Shares in the Cambridge, ...

AstraZeneca is polishing the case for its Imfinzi (durvalumab) and Imjudo (tremelimumab) combo in liver cancer with a new ...

Oricell Therapeutics, a clinical-stage biotech company pioneering cancer immunotherapy, today announced that its lead asset, ...